XOMA Royalty Corp financial data

Symbol
XOMA, XOMAO, XOMAP on Nasdaq
Industry
Pharmaceutical Preparations
Location
2200 Powell Street, Suite 310, Emeryville, CA
Fiscal year end
December 31
Former names
XOMA Corp (to 7/9/2024), XOMA LTD /DE/ (to 1/17/2012), XOMA CORP /DE/ (to 3/19/1998)
Latest financial report
10-K - Q4 2024 - Mar 17, 2025

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 745 % +22%
Debt-to-equity 160 % +238%
Return On Equity -15.8 % +59.3%
Return On Assets -6.09 % +77%
Operating Margin -140 % +84%

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 12M shares +3.04%
Common Stock, Shares, Outstanding 12M shares +3.97%
Entity Public Float 162M USD +30.6%
Common Stock, Value, Issued 90K USD +4.65%
Weighted Average Number of Shares Outstanding, Basic 11.7M shares +2.01%
Weighted Average Number of Shares Outstanding, Diluted 11.7M shares +2.01%

Income Statement

Label TTM Value / Value Unit Change %
Revenues 28.5M USD +499%
Revenue from Contract with Customer, Excluding Assessed Tax 6.65M USD
Research and Development Expense 2.88M USD +1910%
General and Administrative Expense 34.5M USD +34.6%
Operating Income (Loss) -40M USD +4.47%
Income Tax Expense (Benefit) 0 USD
Net Income (Loss) Attributable to Parent -13.8M USD +66.2%
Earnings Per Share, Basic -1.65 USD/shares +59.2%
Earnings Per Share, Diluted -1.65 USD/shares +59.2%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value 102M USD -33.7%
Assets, Current 126M USD -25.8%
Property, Plant and Equipment, Net 32K USD +28%
Operating Lease, Right-of-Use Asset 319K USD -15.6%
Intangible Assets, Net (Excluding Goodwill) 25.9M USD
Other Assets, Noncurrent 1.86M USD +249%
Assets 221M USD -5.56%
Accounts Payable, Current 1.05M USD +61.3%
Liabilities, Current 24.4M USD +25%
Deferred Income Tax Liabilities, Net 5.68M USD +7095%
Operating Lease, Liability, Noncurrent 483K USD +44.2%
Liabilities 139M USD -4.28%
Accumulated Other Comprehensive Income (Loss), Net of Tax 73K USD
Retained Earnings (Accumulated Deficit) -1.24B USD -1.13%
Stockholders' Equity Attributable to Parent 81.9M USD -7.66%
Liabilities and Equity 221M USD -5.56%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities -4.95M USD -0.47%
Net Cash Provided by (Used in) Financing Activities -4.96M USD -262%
Net Cash Provided by (Used in) Investing Activities -7.25M USD -0.17%
Common Stock, Shares Authorized 277M shares 0%
Common Stock, Shares, Issued 12M shares +3.97%
Common Stock, Par or Stated Value Per Share 0.01 USD/shares 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect -17.1M USD -26.8%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents 106M USD -33.3%
Interest Paid, Excluding Capitalized Interest, Operating Activities 3.78M USD
Deferred Tax Assets, Valuation Allowance 85.2M USD +46%
Deferred Tax Assets, Gross 90.8M USD +55.5%
Operating Lease, Liability 929K USD +132%
Payments to Acquire Property, Plant, and Equipment 17K USD
Comprehensive Income (Loss), Net of Tax, Attributable to Parent -13.7M USD +66.3%
Lessee, Operating Lease, Liability, to be Paid 1.03M USD +112%
Operating Lease, Liability, Current 446K USD +726%
Lessee, Operating Lease, Liability, to be Paid, Year Two 300K USD +253%
Lessee, Operating Lease, Liability, to be Paid, Year One 502K USD +505%
Operating Lease, Weighted Average Discount Rate, Percent 0.08 pure -11.8%
Lessee, Operating Lease, Liability, Undiscounted Excess Amount 100K USD +4.17%
Lessee, Operating Lease, Liability, to be Paid, Year Three 91K USD +3.41%
Deferred Tax Assets, Operating Loss Carryforwards 36.7M USD +21.7%
Preferred Stock, Shares Authorized 1M shares 0%
Unrecognized Tax Benefits 5.94M USD 0%
Lessee, Operating Lease, Liability, to be Paid, Year Four 102K USD +12.1%
Operating Lease, Payments 23K USD -55.8%
Additional Paid in Capital 1.32B USD +0.53%
Amortization of Intangible Assets 897K USD
Deferred Tax Assets, Net of Valuation Allowance 5.68M USD +7095%
Preferred Stock, Par or Stated Value Per Share 0.05 USD/shares 0%